Therefore, we investigated the effects of PinX1, miR-200b, and P53 on EMT in nasopharyngeal CD133+ CSCs, aiming to provide new therapeutic targets to prevent distant metastasis and NPC progression. The gene discussed is PROM1; the disease is nasopharyngeal carcinoma.